[1] Ameen M.Chromoblastomycosis:clinical presentation and management[J] ,Clin Exp Dermatol,2009,34 (8):849-854.
[2] Queiroz-Telles F,Esterre P,Perez-Blanco M.Chromoblastomycosis:an overview of clinical manifestations,diagnosis and treatment[J]. Med Mycol,2009,47(1):3-15.
[3] Najafzadeh M J,Sun J,Vicente VA.Molecular epidemiology of Fonsecaea species[J]. Emerg Infect Dis,2011,17(3):464-469.
[4] Esterre P,Andriantsimahavandy A,Ramarcel ER.Forty years of chromoblastomycosis in Madagascar:a review[J]. Am J Trop Med Hyg,1996,55(1):45-47.
[5] Xi L,Sun J,Lu C.Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China[J]. Med Mycol,2009,47(1):27-33.
[6] 万俊增.着色芽生菌病研究进展[J]. 国外医学皮肤性病学分册,1994,20(3):150-153.
[7] De Hoog GS,Attili-Angelis D,Vicente VA.Molecular ecology and pathogenic potential Fonsecaea species[J]. Med Mycol,2004,42:405-416.
[8] Jacobson ES.Pathogenic roles for fungal melanins[J]. Clinical microbiology review,2000,13 (4) ;708-717.
[9] Cunha MM,Franzen AJ,Seabra SH.Melanin in Fonsecaea pedrosoi:a trap for oxidative radicals[J]. BMC Microbiol,2010,10:80-88.
[10] Nóbreqa YK,Lozano VF,de Araújo TS.The cell wall fraction from Fonsecaea pedrosoi stimulates production of different profiles of cytokines and nitric oxide by murine peritoneal cells in vitro[J]. Mycopatholoqia,2010,170(2):89-98.
[11] Alviano DS,Franzen AJ,Travassos LR.Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes[J]. Infect Immun,2004,72 (1):229-237.
[12] Souza ET,Silva-Filho FC,De Souza W.Identification of sialic acids on the cell surface of hyphae and conidia of the human pathogen Fonsecaea pedrosoi[J]. J Med Vet Mycol,1986,24(2):145-154.
[13] Alviano DS,Rodrigues ML,Almeida CA.Differential expression of sialylglycoconjugates and sialidase activity in distinct morphological stages of Fonsecaea pedrosoi[J]. Arch Microbiol,2004,181 (4):278-286.
[14] Kneipp LF,Palmeira VF,Pinheiro AA.Phosphatase activity on the cell wall of Fonsecaea pedrosoi[J]. Med Mycol,2003,41 (6):469-477.
[15] Kneipp LF,Rodrigues ML,Holandino C.Ectophosphatase activity in conidial forms of Fonsecaea pedrosoi is modulated by exogenous phosphate and influences fungal adhesion to mammalian cells[J]. Microbiology,2004,150:3355-3362.
[16] Palmeira VF,Kneipp LF,Alviano CS.The major chromoblastomycosis fungal pathogen,Fonsecaea pedrosoi,extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition:implications on the fungal development and cleavage of key's host structures[J]. FEMS Immunol Med Microbiol,2006,46(1):21-29.
[17] Santos ALS,Palmeira VF,Rozental S.Biology and pathogenesis of Fonsecaea pedrosoi,the major etiologic agent of chromoblastomycosis[J]. FEMS,2007,31 (5):570-591.
[18] Rozental S,Alviano CS,de Souza W.The in vitro susceptibility of Fonsecaeapedrosoito activated macrophages[J]. Mycopathologia,1994,126(2):85-91.
[19] Rozental S,Alviano CS,de Souza W.Fine structure and cytochemical study of the interaction between Fonsecaea pedrosoi and rat polymorphonuclear leukocyte[J]. J Med Vet Mycol,1996,34(5):323-330.
[20] Hayakawa M,Ghosn EE,da Gloria Teixeria de Sousa M.Phagocytosis,production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceous fungi that cause chromoblastomycosis[J]. Scand J Immunol,2006,64(4):382-387.
[21] Takase T,Baba T,Uyeno K.Chromomycosis.A case with a widespread rash,lymph node metastasis and multiple subcutaneous nodules[J]. Mycoses,1988,31(7):343-352.
[22] Corbellini VA,Scroferneker ML,Carissimi M.Delayedtype hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media[J]. Mycopathologia,2006,162(1):51-55.
[23] Da Silva JP,da Silva MB,Salgado UI.Phagocytosis of Fonsecaea pedrosoi conidia,but not sclerotic cells caused by Langerhans cells,inhibits CD40 and B7-2 expression[J]. FEMS Immunol Med Microbiol,2007,50(1):104-111.
[24] Gimenes VMF,Souza MG,Ferreira KS.Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis[J]. Microbes Infect,2005,7(4):708-713.
[25] d'Avlla SC,Pagliari C,Duarte MI.The cell-mediated immune reaction in the cutaneous lesion of Chromoblastomycosis and their correlation with different clinical forms of the disease[J]. Mycopathologia,2003,156(2):51-60.
[26] Teixeira de Sousa Mda G,Ghosn EE,Almeida SR.Absence of CD4 + T cells impairs host defence of mice infected with Fonsecaea pedrosoi[J]. Scand J Immunol,2006,64 (6):595-600.
[27] Sá VC,Silva TA,Reis CM.The pattern of immune cell infiltration in chromoblastomycosis:involvement of macrophage inflammatory protein-1 alpha/CCL3 and fungi persistence[J]. Rev Inst Med Trop Sao Paulo,2007,49(1):49-53.
[28] Tsuneto LT,Arce-Gomez B,Petzl-Erler ML.HLA-A29and genetic susceptibility to chromoblastomycosis[J]. J Med Vet Mycol,1989,27(3):181-185.
[29] Xie Z,Feng P,Zhang J.Molecular cloning,characterization and differential expression of Cdc42 in Fonsecaea monophora[J]. Mol Biol Rep,2011,May 15[Epub ahead of print]
[30] Hernández-Hernández F,De Bievre C,Camacho-Arroyo I.Sex hormone effects on Phialophora verrucosa in vitro and characterization of progesterone receptors[J]. J Med Vet Mycol,1995,33(4):235-239.
[31] López Martínez R,Méndez Tovar LJ.Chromoblastomycosis[J]. Clin Dermatol,2007,25(2):188-194. |
